• Contact quintiles

    Phone:+1 866 267 4479

    Request a Proposal

  • The Latin American Advantage

  • clinical-trials-header
  • Quintiles Clinical Trial

    In Latin America, the $69 billion pharmaceutical sector shows no signs of slowing.

    While mature markets face patent expirations, payer resistance and soaring R&D costs, Latin American growth is predicted to be as much as 11% annually - making it one of the industry's fastest expanding regions.

    Latin America Infographic

    How we help you reap the benefits

    • Our experts use their local knowledge and relationships to streamline trial start up, contributing to our global 87% on-time enrollment rate.
    • Our regulatory specialists assess protocol design and study feasibility, even in placebo-controlled studies. The result? An uncommonly high rate of approval.
    • We can guide you through the regulatory landscape. From 2006 to 2011, we obtained 50 Latin American dossier registrations and more than 80 post-approval submissions, including renewals, variations and labeling updates.
    • Latin American countries are making a concerted - and successful - effort to improve trial practices and standards. To date, 90% of the trials we've helped conduct in the region have been part of successful US and European drug submissions.
    • We help you gain market access by leveraging relationships with payers and providers to make your drugs available to a wider population.
    • To promote your products and marketing messages to all audiences, we offer a range of commercial services, including customized sales forces, market penetration strategies and brand solutions.

  • Find out what waits for you in Latin America

  • Quintiles Clinical Trails

    With three of the region’s largest cities and nearly 205 million people, Brazil is increasingly part of global drug development strategies. Find out why

  • Quintiles Clinical Trails

    Ready to expand into Latin America? Our consultants combine strategy, data and expertise to help you navigate challenges and optimize operations.  Learn more

  • Quintiles Clinical Trails

    Why is Latin America an ideal location for Phase II-IV studies? Skilled investigators, diverse patient populations and rapid access to both. Get the facts